Daily non-political popular news in brief.
Study reveals why certain ovarian cancers develop resistance to platinum-based chemotherapy
02-10-2008 · EurekAlert!A team of researchers led by Fred Hutchinson Cancer Research Center has identified a new mechanism that explains why some recurrent ovarian tumors become resistant to treatment with commonly used platinum-based chemotherapy drugs such as cisplatin and carboplatin.
Read more »
Keywords: study, reveals, certain, ovarian, cancers, develop, resistance, platinum-based, chemotherapy, reveal, cancer, platinum, based
« Previous | Next »
Similar news on "Study reveals why certain ovarian cancers develop resistance to platinum-based chemotherapy":
- Survivors of rare ovarian cancer retain fertility, have positive relationships, study finds
06-29-2007 · EurekAlert!
Ovarian germ cell tumor patients treated with platinum-based chemotherapy and fertility-sparing surgery are likely to retain their menstrual function and reproductive ability, according to the largest and most comprehensive survey of survivors ever conducted.
Similar news · Read more »
- Extracellular protein sensitizes ovarian cancer cells to chemotherapy
12-10-2007 · EurekAlert!
Scientists have uncovered critical new details about the mechanisms that modulate the response of ovarian cancer cells to chemotherapy. The research, published by Cell Press in the December issue of Cancer Cell, helps to explain why many patients develop resistance to the taxane class of drugs and may lead to improved treatment of ovarian cancer.
Similar news · Read more »
- Cisplatin is more effective than carboplatin for treating nonsmall cell lung cancer
06-05-2007 · EurekAlert!
Some patients with advanced nonsmall cell lung cancer have slightly higher survival rates when treated with the chemotherapy drug cisplatin than another platinum-based drug, carboplatin, according to a study in the June 6 Journal of the National Cancer Institute. The authors conclude that cisplatin chemotherapy should remain the standard of care for these patients.
Similar news · Read more »
- Cranberries may improve chemotherapy for ovarian cancer
08-21-2007 · EurekAlert!
Compounds in cranberries may help improve the effectiveness of platinum drugs that are used in chemotherapy to fight ovarian cancer, researchers have found in a controlled laboratory study. The scientists found that human ovarian cancer cells resistant to platinum drugs became up to six times more sensitized to the drugs after exposure to the cranberry compounds. The study will be described in August at the American Chemical Society national meeting in Boston.
Similar news · Read more »
- Surgical biopsy may reveal cancer in women with rare but benign breast condition
11-10-2006 · EurekAlert!
A study at Washington University School of Medicine in St. Louis showed that in women whose initial breast biopsies revealed certain rare, yet benign breast conditions, more extensive follow-up surgical biopsies found cancer up to 25 percent of the time. Most of the cancers were invasive, meaning the tumors had penetrated normal breast tissue and would require treatment.
Similar news · Read more »
- VEGF Trap shows activity in patients with advanced ovarian cancer
06-02-2007 · EurekAlert!
Preliminary results of a randomized, international Phase II trial of VEGF Trap (aflibercept) show activity in patients with recurrent epithelial ovarian cancer (EOC) who had received three or four prior chemotherapy regimens and had become resistant to platinum-based chemotherapy agents. The findings, which are being presented today at the American Society of Clinical Oncology’s annual meeting, may indicate a role for this targeted therapy in women with ovarian cancer who have exhausted all other options.
Similar news · Read more »
- Sunshine pill for prostate cancer in 2009
01-16-2007 · EurekAlert!
A drug based on vitamin D and is given to patients in the advanced stages of prostate cancer along with chemotherapy drugs could be availiable by 2009. Vitamin D from sunlight improves the prognosis of certain cancers, but taking natural levels of the vitamin has no effect. Novacea, the company that makes Asentar, produced a novel formulation that reproduces the healing effect without the dangerous side-effects of a vitamin D overdose.
Similar news · Read more »
- Survey reveals need for standardized oral chemotherapy prescribing practices, safeguards
01-11-2007 · EurekAlert!
Despite the widespread use of prescribing safeguards for infusion chemotherapy, few of those measures have been implemented with oral chemotherapy, according to a study led by researchers at Dana-Farber Cancer Institute.
Similar news · Read more »
- Chemotherapy can be more toxic to brain cells than to cancer cells and may cause brain damage
11-29-2006 · EurekAlert!
Drugs used to treat cancer may damage normal, healthy brain cells more than the cancer cells they are meant to target. A study published today in the open access journal Journal of Biology shows that clinical doses of chemotherapeutic drugs used to treat many common cancers cause long-term damage to the brains of mice.
Similar news · Read more »
- Study of malaria parasites reveals new parasitic states
11-28-2007 · EurekAlert!
Although malaria parasites have undergone extensive laboratory study, relatively little is known about how they behave in humans to cause disease. Newly published data from a study of malaria-infected human blood reveal two biological states of the parasite Plasmodium falciparum not observed under laboratory conditions. This information may help scientists develop new strategies for treating malaria.
Similar news · Read more »
